Junfei Gu

4PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 20, 2026
Synergistic anticancer effects of cabozantinib and cuproptosis induction driven by DHRS2-KAT2A-H3K27ac axis in clear cell renal cell carcinoma.

Yilong Cao, Chao Xu, Bowei Zhang

|Oct 08, 2025
ERβ/circAHNAK Axis Inhibits USP10-FMR1 Deubiquitination to Prevent m⁶A-Mediated ADAM17 Decay and Promote Angiogenesis in Clear Cell Renal Cell Carcinoma.

Chao Xu, Sujing Zhang, Yuepeng Liu

|Aug 16, 2023
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer.

Hongzhuang Wen, Changbao Qu, Zhu Wang

|Oct 14, 2022
Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma.

Chao Xu, Bolin Jia, Zhan Yang

Pageof 1

Frequent Collaborators

1 joint publications

Bolin Jia

1 joint publications

Hongzhuang Wen

1 joint publications

Changbao Qu

1 joint publications

Zhu Wang